Meridian Bioscience Inc. (VIVO)
NASDAQ: VIVO
· Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM
Meridian Bioscience Revenue Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics Revenue | 39.37M | 39.19M | 42.41M | 41.1M | 33.2M | 34.3M | 31.19M | 31.95M | 30.32M | 29.8M | 700K | 34.94M | 34.79M | 33.4M | 33.12M | 33.5M | 36.66M | 36.81M | 36.37M | 39.78M | 37.49M | 35.99M | 35.95M | 37.77M | 33.81M | 34.94M | 70K | 84K | 71K | 99K | 46K | 84K | 104K | 70K | 35.17M | 37.06M | 34.84M | 11.71M | 11.8M | 350K | 158K | 304K | 133K | 324K | 336K | 10.96M |
| Diagnostics Revenue Growth | +0.46% | -7.60% | +3.18% | +23.79% | -3.20% | +9.98% | -2.38% | +5.37% | +1.74% | +4157.29% | -98.00% | +0.43% | +4.17% | +0.85% | -1.14% | -8.63% | -0.40% | +1.23% | -8.58% | +6.11% | +4.16% | +0.12% | -4.83% | +11.73% | -3.23% | +49808.57% | -16.67% | +18.31% | -28.28% | +115.22% | -45.24% | -19.23% | +48.57% | -99.80% | -5.11% | +6.38% | +197.50% | -0.79% | +3272.29% | +121.52% | -48.03% | +128.57% | -58.95% | -3.57% | -96.93% | n/a |
| Life Science Revenue | 17.54M | 26.49M | 25.36M | 70.13M | 55.14M | 41.9M | 32.32M | 53.31M | 62.6M | 34.35M | 63.2M | 22.35M | 12.63M | 17.45M | 15.32M | 16.75M | 14.81M | 16.29M | 15.37M | 16.67M | 14.79M | 13.71M | 14.19M | 16.35M | 13M | 12.06M | 201K | 387K | 367K | 433K | 345K | 226K | 297K | 151K | 12.04M | 13.07M | 9.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Life Science Revenue Growth | -33.80% | +4.44% | -63.83% | +27.19% | +31.58% | +29.64% | -39.38% | -14.83% | +82.22% | -45.64% | +182.72% | +76.99% | -27.61% | +13.87% | -8.51% | +13.05% | -9.03% | +5.97% | -7.80% | +12.68% | +7.94% | -3.42% | -13.22% | +25.78% | +7.78% | +5901.00% | -48.06% | +5.45% | -15.24% | +25.51% | +52.65% | -23.91% | +96.69% | -98.75% | -7.87% | +31.29% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 19.37M | 18.62M | 21.33M | 26.58M | 22.68M | 19.83M | 18.61M | 20.5M | 11.94M | 20.59M | 18.83M | 17.73M | 15.76M | 17.52M | 14.75M | 14.3M | 16.46M | 11.73M | 17.79M | 21.22M | 19.23M | 17.39M | 16.36M | 15.44M | 15.96M | 16.39M | 15.62M | 15.29M | 14.62M | 13.61M | 12.72M | 13.42M |
| Selling, General, and Administrative Revenue Growth | +3.99% | -12.67% | -19.75% | +17.17% | +14.37% | +6.56% | -9.19% | +71.68% | -42.01% | +9.31% | +6.23% | +12.49% | -10.06% | +18.80% | +3.15% | -13.16% | +40.32% | -34.06% | -16.13% | +10.33% | +10.60% | +6.28% | +5.97% | -3.27% | -2.64% | +4.93% | +2.19% | +4.59% | +7.38% | +7.02% | -5.23% | n/a |
| Research and Development Revenue | 6.18M | 6.41M | 6.04M | 5.69M | 6.19M | 6.11M | 6.08M | 6.07M | 5.65M | 6.78M | 6.74M | 5.39M | 4.82M | 5.65M | 4.59M | 3.82M | 3.97M | 3.63M | 4.26M | 4.22M | 4.5M | 4.46M | 3.91M | 3.91M | 3.4M | 3.76M | 3.55M | 3.13M | 3.38M | 2.92M | 3.21M | 3.37M |
| Research and Development Revenue Growth | -3.59% | +6.02% | +6.19% | -8.12% | +1.34% | +0.48% | +0.30% | +7.33% | -16.60% | +0.49% | +25.19% | +11.65% | -14.68% | +23.07% | +20.39% | -3.81% | +9.43% | -14.89% | +0.88% | -6.09% | +0.76% | +14.23% | -0.03% | +14.74% | -9.42% | +6.01% | +13.33% | -7.45% | +15.79% | -9.15% | -4.57% | n/a |
| Sales and Marketing Revenue | 8.29M | 7.84M | 8.18M | 7.51M | 7.74M | 7.01M | 6.21M | 6.54M | 7.02M | 7.03M | 6.26M | 6.51M | 6.68M | 7.22M | 6.75M | 6.91M | 7.56M | 8.51M | 8.5M | 8.65M | 8.84M | 8.69M | 7.88M | 8.01M | 7.51M | 8.13M | 8.09M | 7.21M | 6.44M | 6.86M | 6.18M | 6.48M |
| Sales and Marketing Revenue Growth | +5.79% | -4.13% | +8.84% | -2.93% | +10.43% | +12.90% | -5.06% | -6.85% | -0.09% | +12.23% | -3.88% | -2.54% | -7.49% | +7.08% | -2.37% | -8.62% | -11.09% | +0.02% | -1.67% | -2.19% | +1.75% | +10.21% | -1.59% | +6.63% | -7.61% | +0.59% | +12.14% | +11.90% | -6.02% | +10.87% | -4.58% | n/a |